Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Research crawled date : 2022 - 10 - 26 save search
Revolutionary progress made in the inaugural year of the Panacea Cannabinoid Research Center at Colorado State University
Published: 2022-10-26 (Crawled : 16:00) - globenewswire.com
PLSH | $0.19 -35.6% 100
|
n/a
| Email alert
Add to watchlist
research state year
White Oil Market to Garner $3.1 Billion, Globally, By 2031 at 3.7% CAGR, Says Allied Market Research
Published: 2022-10-26 (Crawled : 13:20) - prnewswire.com
SNPTY | $46.175
|
n/a
|
| O: -4.48%
H: 5.55%
C: 3.34%
RYDAF | $35.2 -7.36% 400
|
Energy Minerals
|
| O: 2.58%
H: 0.02%
C: -2.29%
XOM | News | $119.88 1.15% -0.01% 21M
|
Energy Minerals
|
| O: 0.36%
H: 1.48%
C: 0.83%
EMN | $96.42 0.42% 0.0% 700K
|
Process Industries
|
| O: 0.2%
H: 1.62%
C: 0.21%
research market
Jaguar Health Announces Publication in Breast Cancer Research and Treatment of Investigator-Initiated Phase 2 HALT-D Study of Crofelemer for Prevention of Chemotherapy-Induced Diarrhea (CID) in Breast Cancer Patients
Published: 2022-10-26 (Crawled : 13:00) - jaguarhealth.gcs-web.com
JAGX | $0.158 -10.79% -12.09% 30M
|
Health Technology
|
| O: -0.35%
H: 2.85%
C: 2.56%
treatment research diarrhea breast health crofelemer cancer publication study
Alterity Therapeutics Announces Presentation of MRI Data from the bioMUSE Natural History Study at the American Neurological Association Annual Meeting
Published: 2022-10-26 (Crawled : 12:00) - biospace.com/
ATHE | $2.04 -4.67% -4.9% 54K
|
Health Technology
|
| O: 1.64%
H: 2.2%
C: -4.42%
meeting neurological therapeutics presentation study
TG Therapeutics Announces Presentation of Exploratory Analyses from the ULTIMATE I & II Phase 3 Trials of Ublituximab in Multiple Sclerosis Presented at the 2022 European Committee for Treatment and Research in Multiple Sclerosis
Published: 2022-10-26 (Crawled : 12:00) - globenewswire.com
TGTX | $13.79 -1.43% -1.45% 3.7M
|
Health Technology
|
| O: -0.93%
H: 11.07%
C: 3.75%
treatment trials research therapeutics presentation sclerosis multiple sclerosis
Clarivate Identifies the Role of Research and Innovation in the World's Shift to Sustainable Energy
Published: 2022-10-26 (Crawled : 08:00) - prnewswire.com
CLVT | $6.99 0.58% 0.0% 4.1M
|
Information
|
| O: -0.39%
H: 3.12%
C: 1.19%
research energy innovation
Gainers vs Losers
| 67% | 33% |
Top 10 Gainers
AGBA | News | $1.26 215.0% 68.25% 130M
|
Finance
EGOX | $0.0515 43.06% 30.1% 330M
|
OLB 4 | $0.33 -14.95% 25.53% 840K
|
Technology Services
NVFY | $2.77 31.28% 23.83% 33M
|
Consumer Durables
ZCMD | $1.87 28.97% 22.46% 31M
|
Commercial Services
RCON | $0.1112 13.01% 21.28% 1.7M
|
Distribution Services
INSG | $3.03 25.21% 20.13% 330K
|
Electronic Technology
GCTK | $0.8191 22.25% 18.2% 190K
|
Manufacturing
WLGS | $0.59 18.0% 17.9% 2.3M
|
ASNS | $0.828 21.75% 17.86% 18K
|
Your saved searches
Save your searches and get alerts when important news are released.